Comparison of three intravenous regimens of clodronate in Paget disease of bone

Journal of Bone and Mineral Research

Volumn 11, Issue 2, 1996, Pages 178-182

  Khan, Sohail A ^a   Mccloskey, Eugene V ^a   Eyres, Keith S ^a   Nakatsuka, Kiyoshi ^a   Sirtori, Paulo ^a   Orgee, Jane ^a   Coombes, Gillian ^a   Kanis, John A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; HYDROXYPROLINE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; DISEASE ACTIVITY; DRUG EFFECT; DRUG INFUSION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; PAGET BONE DISEASE; RETROSPECTIVE STUDY; URINARY EXCRETION;

EID: 0030019794     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110206     Document Type: Article

References (24)

1. Fleisch H 1991 Bisphosphonates: pharmacology and use in the treatment of tumour induced hypercalcaemia and metastatic bone disease. Drugs 42:919-944.
2. Kanis JA 1984 Monitoring the treatment of Paget's disease with etidronate. Calcif Tissue Int 36:629-631.
3. Boyce BF, Smith L. Fogelman I, Johnson E, Ralston S, Boyle IT 1984 Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease. Lancet i:821-824.
4. Nagant de Deuxchaisnes C. Dufour JP, Devogelaer JP, Huaux JP 1985 Etidronate and the risk of fractures. Lancet ii:610-611.
5. Gibbs CJ, Aaron JE, Peacock M 1986 Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate. Br Med J 292:1227-1229.
6. Eyres KS, Marshall P, McCloskey EV, Douglas DL, Kanis JA 1992 Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate). Drug Safety 7:162-165.
7. Fogelman I, Smith L, Mazess R, Wilson MA, Bevan JA 1986 Absorption of oral diphosphonate in normal subjects. Clin Endocrinol 24:57-62.
8. Kanis JA, Urwin GH, Gray RES, Benéton MNC, McCloskey EV, Hamdy NAT, Murray SA 1987 Effects of intravenous etidronate disodium on skeletal and calcium metabolism. Am J Med 82 (Suppl 2A):55-70.
9. McCloskey EV, Yates AJP, Benéton MNC, Galloway J, Harris S, Kanis JA 1987 Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man. Bone 8 (Suppl 1):35-42.
10. 2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Int 11:196-214.
11. Yates APJ, Gray RES, Urwin G, Preston CJ, Russell RGG, Percival RC, Atkins RM, Hamdy NAT, Benéton MNC, Kanis JA 1985 Intravenous clodronate in the treatment and retreatment of Paget's disease of bone. Lancet 1:1474-1477.
12. Douglas DL, Russell RGG, Preston CJ, Prenton MA, Duck-worth T, Kanis JA, Preston FE, Woodhead JS 1980 Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hyperparathyroidism or malignant disease. Lancet 1:1043-1047.
13. Urwin GH, Yates AJP, Gray RES, Hamdy NAT, McCloskey EV, Preston FE, Greaves M, Neil FE. Kanis JA 1987 Treatment of the hypercalcaemia of malignancy with intravenous clodronate. Bone 8(Suppl 1):43-51.
14. O'Rourke NP, McCloskey EV, Neugebauer G, Kanis JA 1994 Renal and non-renal clearance of clodronate in patients with malignancy and renal impairment. Drug Invest 7:26-33.
15. Stegeman H, Stalder K 1967 Determination of hydroxyproline. Clin Chim Acta 18:267-273.
16. Gray RES, Yates APJ, Preston CJ, Smith R, Russell RGG, Kanis JA 1987 Duration of effects of oral diphosphonate therapy in Paget's disease of bone. Q J Med 245:755-767.
17. Walton RJ, Preston CJ, Bartlett M, Smith R, Russell RGG 1977 Biochemical measurements in Paget's disease of bone. Distribution and correlations. Eur J Clin Invest 7:37.
18. Kaplan EL, Meier P 1958 Non-parametric estimation from incomplete observations. J Am Statistical Assoc 53:457-481.
19. Altman DG 1992 Practical Statistics for Medical Research. Chapman and Hill, London, pp. 370-371.
20. Kanis JA 1991 Pathophysiology and Treatment of Paget's Disease of Bone. Martin Dunitz, London.
21. Yakatan CJ, Poynor WJ, Talbert RL, Floyd BF, Slough CL 1982 Clodronate kinetics and bioavailability. Clin Pharmacol Ther 31:402-410.
22. Kanis JA, Gray RES 1987 Long-term follow-up observations on treatment in Paget's disease of Bone. Clin Orthop 217:99-125.
23. Atkins RM, Yates APJ, Gray RES, Urwin GH, Hamdy NAT, Benéton MNC, Rosini S, Kanis JA 1987 Aminohexane diphosphonate in the treatment of Paget's disease of bone. J Bone Miner Res 4:273-279.
24. Altman RD 1985 Long-term follow up of therapy with intermittent etidronate disodium in Paget's disease of bone. Am J Med 79:583-590.